Company intelligence / Profile preview

GenNext Technologies

Half Moon Bay / Montara, California, United Statesgnxtech.com ↗

Ownership: Private
Development stage: Commercial

Overview

GenNext’s Fox/HRPF systems are used by leading biopharmaceutical companies worldwide for higher order structure analysis of proteins. The company has received significant NIH grant funding (~$7M), holds seminal patents in the field, and has generated revenue from product sales. Their technologies accelerate drug discovery by enabling detailed structural characterization of protein therapeutics.

Therapeutic areas: Other
Modalities: Monoclonal antibodyProtein
Industry: Drug Discovery Services

Partnerships

Thermo Fisher ScientificAgilent TechnologiesSCIEX

Beyond the preview

Go deeper on GenNext Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GenNext Technologies.

Explore the full profile